Phosphatidylinositol 4,5-Diphosphate [fosfatidylinositol-4,5-difosfát]
- Terms
-
Phosphatidylinositol 4,5-Biphosphate
Phosphatidylinositol Phosphate, PtdIns(4,5)P2
Phosphatidylinositol-4,5-Biphosphate
PtdIns(4,5)P2
PtdInsP
PtdInsP2
PtIns 4,5-P2
A phosphoinositide present in all eukaryotic cells, particularly in the plasma membrane. It is the major substrate for receptor-stimulated phosphoinositidase C, with the consequent formation of inositol 1,4,5-triphosphate and diacylglycerol, and probably also for receptor-stimulated inositol phospholipid 3-kinase. (Kendrew, The Encyclopedia of Molecular Biology, 1994)
- DUI
- D019269 MeSH Browser
- CUI
- M0028698
- Previous indexing
- Phosphatidylinositol Phosphates (1994-1996); Phosphatidylinositols (1981-1993)
- History note
- 97; see PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE (NM) 1981-96
- Online note
- use PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE (NM) to search PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE 1981-96
- Public note
- 97; PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE was indexed under PHOSPHATIDYLINOSITOL PHOSPHATES 1994-96 & PHOSPHOINOSITIDES 1981-93
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BI
- biosynthesis
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry 5
- CL
- classification
- DF
- deficiency
- EC
- economics
- GE
- genetics 3
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism 25
- PK
- pharmacokinetics
- PD
- pharmacology 2
- PH
- physiology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UR
- urine